Oncothyreon Inc.·4

Dec 16, 7:19 PM ET

Oncothyreon Inc. 4

4 · Oncothyreon Inc. · Filed Dec 16, 2014

Insider Transaction Report

Form 4
Period: 2014-12-16
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
  • Award

    Stock Option (right to buy)

    2014-12-16+300,000300,000 total
    Exercise: $1.76Exp: 2022-12-16Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]The option vests and is exercisable at the rate of 1/4th of the total shares on December 16, 2015 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on December 16, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION